Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PG545 |
Synonyms | |
Therapy Description |
Pixatimod (PG545) is a heparan sulfate mimetic capable of inhibiting both heparanase and angiogenesis, which may result in tumor growth inhibition and anti-metastatic activity (PMID: 21285983, PMID: 32274726). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PG545 | Pixatimod | Pixatimod (PG545) is a heparan sulfate mimetic capable of inhibiting both heparanase and angiogenesis, which may result in tumor growth inhibition and anti-metastatic activity (PMID: 21285983, PMID: 32274726). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|